1-4 of 4
Vasudha Bal, MSc, MBA
Close
Sort by
Journal Articles

Cost-Effectiveness Analysis of Ofatumumab As a Treatment for Relapsed Chronic Lymphocytic Leukemia in the United States

Gabriel Tremblay, DBA, MSc, BA, Anna Forsythe, PharmD, MSc, MBA, Vasudha Bal, MSc, MBA, Snigdha Santra, MS, MPH, Andrew Briggs, MSc, DPhil
Journal: Blood
Blood (2016) 128 (22): 2366.
https://doi.org/10.1182/blood.V128.22.2366.2366
Published: 2016
Journal Articles

Comparative Safety Analysis of Currently Approved Anti-CD20 Monoclonal Antibodies for First Line Treatment of Chronic Lymphocytic Leukemia (CLL)

Mkaya Mwamburi, PhD MD MA, Vasudha Bal, MSc, MBA, Teresa Cascella, MD, Anshul Shah, B.Pharm, MS, Merena Nanavaty, B. Pharm, MS, Smeet Gala, B.Tech, MS
Journal: Blood
Blood (2016) 128 (22): 5587.
https://doi.org/10.1182/blood.V128.22.5587.5587
Published: 2016
Journal Articles

Impact of Dose-Difference in Comparator Arms Among Clinical Trials on Treatment Effect Size in a Network Meta-Analysis: A Case of First-Line Therapies in Chronic Lymphocytic Leukemia (CLL)

Mkaya Mwamburi, PhD MD MA, Vasudha Bal, MSc, MBA, Teresa Cascella, MD, Anshul Shah, B.Pharm, MS, Merena Nanavaty, B. Pharm, MS, Smeet Gala, B.Tech, MS
Journal: Blood
Blood (2016) 128 (22): 5593.
https://doi.org/10.1182/blood.V128.22.5593.5593
Published: 2016
Journal Articles

Patient and Caregiver Perspectives of Factors Associated with Adherence to and Satisfaction with Iron Chelation Therapy

Vasudha Bal, MSc, MBA, Isabelle Cote, PhD, Kathryn Lasch, PhD MA, MSSW, BA, Vicky Huang, MS
Journal: Blood
Blood (2014) 124 (21): 2166.
https://doi.org/10.1182/blood.V124.21.2166.2166
Published: 2014